Literature DB >> 15955292

Complementary and alternative medicine use in patients with haematological malignancies in Europe.

Alexander Molassiotis1, Anita Margulies, Paz Fernandez-Ortega, Dorit Pud, Vassiliki Panteli, Ingrid Bruyns, Julia A Scott, Gudbjorg Gudmundsdottir, Maria Browall, Elin Madsen, Gulten Ozden, Miriam Magri, Sarka Selvekerova, Nurgun Platin, Nora Kearney, Elisabeth Patiraki.   

Abstract

This study reports upon a descriptive cross-sectional survey assessing the use of complementary and alternative medicine (CAM) in patients with haematological cancers. Twelve European countries contributed data from patients with haematological cancers, as part of a larger study. Sixty-eight patients with haematological cancer participated. Among the participants, 26.5% used some form of CAM after the cancer diagnosis. The most common therapies used were homeopathy (38.9%), herbal medicine (22.2%) various psychic therapies, such as use of mediums, healers, rebirthing or past life regression therapy (22.2%). A particular profile of a CAM user was not evident in the sample. Moderate levels of satisfaction with CAM were reported. Patients commonly used CAM to increase the ability of their body to fight cancer and to improve physical and emotional well-being. Information about CAM was received mainly from friends or family. As CAM use in patients with haematological malignancies is common, clinicians should assist patients who want to use CAM to make an appropriate decision, and improve communication with them about CAM use in an open and non-judgemental dialogue.

Entities:  

Mesh:

Year:  2005        PMID: 15955292     DOI: 10.1016/j.ctcp.2004.12.005

Source DB:  PubMed          Journal:  Complement Ther Clin Pract        ISSN: 1744-3881            Impact factor:   2.446


  14 in total

1.  Is chiropractic a CAM therapy or is it a separate profession?

Authors:  Lon Morgan
Journal:  J Can Chiropr Assoc       Date:  2005-09

2.  [Use of alternative medicine for cancer and impact on survival].

Authors:  Kilian Schiller; Stephanie E Combs
Journal:  Strahlenther Onkol       Date:  2018-09       Impact factor: 3.621

Review 3.  Complementary and Integrative Medicine in Hematologic Malignancies: Questions and Challenges.

Authors:  Moshe Frenkel; Kenneth Sapire
Journal:  Curr Oncol Rep       Date:  2017-10-14       Impact factor: 5.075

4.  Widespread use of complementary and alternative medicine among non-Hodgkin lymphoma survivors.

Authors:  Sarah Rausch Osian; Alexis D Leal; Cristine Allmer; Matthew J Maurer; Grezegorz Nowakowski; David J Inwards; William R Macon; Shawna L Ehlers; George J Weiner; Thomas M Habermann; James R Cerhan; Carrie A Thompson
Journal:  Leuk Lymphoma       Date:  2014-06-27

Review 5.  Biofield therapies: helpful or full of hype? A best evidence synthesis.

Authors:  Shamini Jain; Paul J Mills
Journal:  Int J Behav Med       Date:  2010-03

6.  Survey on the worldwide Chronic Myeloid Leukemia Advocates Network regarding complementary and alternative medicine.

Authors:  Thomas Elsner; Ralph Muecke; Oliver Micke; Franz J Prott; Karsten Muenstedt; Anita Waldmann; Jan Geissler; Jutta Huebner
Journal:  J Cancer Res Clin Oncol       Date:  2013-03-16       Impact factor: 4.553

Review 7.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

8.  The use of herbal medicines by people with cancer: a cross-sectional survey.

Authors:  S Damery; C Gratus; R Grieve; S Warmington; J Jones; P Routledge; S Greenfield; G Dowswell; J Sherriff; S Wilson
Journal:  Br J Cancer       Date:  2011-03-01       Impact factor: 7.640

9.  Use of Chinese medicine by cancer patients: a review of surveys.

Authors:  Bridget Carmady; Caroline A Smith
Journal:  Chin Med       Date:  2011-06-09       Impact factor: 5.455

10.  Amelioration of carcinogen-induced toxicity in mice by administration of a potentized homeopathic drug, natrum sulphuricum 200.

Authors:  Nandini Bhattacharjee; Surajit Pathak; Anisur Rahman Khuda-Bukhsh
Journal:  Evid Based Complement Alternat Med       Date:  2007-06-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.